TRIESTE, LEOPOLDO Statistiche
TRIESTE, LEOPOLDO
DIPARTIMENTO DI FARMACIA
Rehabilitation with and without Robot and Allied Digital Technologies (RADTs) in stroke patients: a study protocol for a multicentre Randomised Controlled Trial on the effectiveness, acceptability, usability, and economic-organizational sustainability of RADTs from subacute to chronic phase (STROKEFIT4)
2024-01-01 Giovanna Aprile, Irene; Germanotta, Marco; Fasano, Alessio; Siotto, Mariacristina; Cristina Mauro, Maria; Pavan, Arianna; Nicora, Giovanna; Sgandurra, Giuseppina; Malovini, Alberto; Oreni, Letizia; Dubbini, Nevio; Parimbelli, Enea; Comandè, Giovanni; Lunetta, Christian; Fiore, Pietro; De Icco, Roberto; Trompetto, Carlo; Trieste, Leopoldo; Turchetti, Giuseppe; Quaglini, Silvana
TABLET TOSCANA to Develop Innovative Organizational Models for Tele-Rehabilitation in Subjects with Congenital and Acquired Developmental Disabilities: A Wait-List Control Group Trial Protocol
2024-01-01 Barzacchi, V.; Mangani, G.; Del Lucchese, B.; Menici, V.; Bombonato, C.; Beani, E.; Biagioni, E.; Palla, I.; Posteraro, F.; Trieste, L.; Turchetti, G.; Sgandurra, G.; Cioni, G.
Correction to: RarERN Path: a methodology towards the optimisation of patients’ care pathways in rare and complex diseases developed within the European Reference Networks (Orphanet Journal of Rare Diseases, (2020), 15, 1, (347), 10.1186/s13023-020-01631-1)
2021-01-01 Talarico, R.; Cannizzo, S.; Lorenzoni, V.; Marinello, D.; Palla, I.; Pirri, S.; Ticciati, S.; Trieste, L.; Triulzi, I.; Terol, E.; Bucher, A.; Turchetti, G.
Longitudinal adherence trajectories to biologic disease modifying anti-rheumatic drugs in Tuscany, Italy
2021-01-01 Giometto, S; Convertino, I; Tuccori, M; Gini, R; Cazzato, M; Valdiserra, G; Cappello, E; Ferraro, S; Tillati, S; Fornili, M; Bartolini, C; Paoletti, O; Turchetti, G; Trieste, L; Lorenzoni, V; Blandizzi, C; Mosca, M; Lucenteforte, E
Utilisation patterns and clinical impact of the introduction of infliximab-biosimilar in Tuscany, Italy: real world evidence following the recommendation of switching for non-medical reasons
2021-01-01 Convertino, Irma; Lucenteforte, Ersilia; Gini, Rosa; Lorenzoni, Valentina; Cazzato, Massimiliano; Turchetti, Giuseppe; Trieste, Leopoldo; Ferraro, Sara; Leonardi, Luca; Roberto, Giuseppe; Luciano, Nicoletta; Blandizzi, Corrado; Mosca, Marta; Tuccori, Marco
Validation of algorithms for selecting rheumatoid arthritis patients in the Tuscan healthcare administrative databases
2021-01-01 Convertino, I.; Cazzato, M.; Giometto, S.; Gini, R.; Valdiserra, G.; Cappello, E.; Ferraro, S.; Tillati, S.; Bartolini, C.; Paoletti, O.; Lorenzoni, V.; Trieste, L.; Filippi, M.; Turchetti, G.; Cristofano, M.; Blandizzi, C.; Mosca, M.; Lucenteforte, E.; Tuccori, M.
Validation test for algorithms to identify rheumatoid arthritis patients in the Tuscan healthcare administrative databases
2021-01-01 Convertino, I; Cazzato, M; Giometto, S; Gini, R; Lucenteforte, E; Valdiserra, G; Cappello, E; Ferraro, S; Tillati, S; Fornili, M; Bartolini, C; Paoletti, O; Lorenzoni, V; Trieste, L; Filippi, M; Turchetti, G; Cristofano, M; Blandizzi, C; Mosca, M; Tuccori, M
RarERN Path: a methodology towards the optimisation of patients’ care pathways in rare and complex diseases developed within the European Reference Networks
2020-01-01 Talarico, Rosaria; Cannizzo, Sara; Lorenzoni, Valentina; Marinello, Diana; Palla, Ilaria; Pirri, Salvatore; Ticciati, Simone; Trieste, Leopoldo; Triulzi, Isotta; Terol, Enrique; Bucher, Anna; Turchetti, Giuseppe
Trajectories of use of biologic disease modifying antirheumatic drugs in rheumatoid arthritis: A cohort study of Tuscan patients, Italy
2020-01-01 Convertino, I; Giometto, S; Gini, R; Cazzato, M; Valdiserra, G; Cappello, E; Ferraro, S; Fornili, M; Turchetti, G; Lorenzoni, V; Trieste, L; Mosca, M; Blandizzi, C; Tuccori, M; Lucenteforte, E
Recommendations by the Tuscan Health Authority to Use Infliximab-Biosimilar in the Clinical Practice: Safety Impact
2019-01-01 Convertino, I; Lucenteforte, E; Lorenzoni, V; Turchetti, G; Trieste, L; Roberto, G; Cazzato, M; Mosca, M; Ferraro, S; Leonardi, L; Luciano, N; Gini, R; Blandizzi, C; Tuccori, M
Switching from infliximab-originator to infliximab-biosimilar in rheumatologic patients: The clinical impact in Tuscan Region, Italy
2019-01-01 Convertino, I; Tuccori, M; Lucenteforte, E; Mosca, M; Turchetti, G; Lorenzoni, V; Trieste, L; Ferraro, S; Leonardi, L; Roberto, G; Luciano, N; Blandizzi, C; Gini, R
The Economic Impact of the Introduction of Infliximab-Biosimilar: Preliminary Results from a Study on Rheumatologic Patients in Tuscany, Italy
2019-01-01 Lorenzoni, V; Trieste, L; Mosca, M; Convertino, I; Tuccori, M; Lucenteforte, E; Ferraro, S; Leonardi, L; Roberto, G; Luciano, N; Blandizzi, C; Gini, R; Turchetti, G
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Rehabilitation with and without Robot and Allied Digital Technologies (RADTs) in stroke patients: a study protocol for a multicentre Randomised Controlled Trial on the effectiveness, acceptability, usability, and economic-organizational sustainability of RADTs from subacute to chronic phase (STROKEFIT4) | 1-gen-2024 | Giovanna Aprile, Irene; Germanotta, Marco; Fasano, Alessio; Siotto, Mariacristina; Cristina Mauro, Maria; Pavan, Arianna; Nicora, Giovanna; Sgandurra, Giuseppina; Malovini, Alberto; Oreni, Letizia; Dubbini, Nevio; Parimbelli, Enea; Comandè, Giovanni; Lunetta, Christian; Fiore, Pietro; De Icco, Roberto; Trompetto, Carlo; Trieste, Leopoldo; Turchetti, Giuseppe; Quaglini, Silvana | |
| TABLET TOSCANA to Develop Innovative Organizational Models for Tele-Rehabilitation in Subjects with Congenital and Acquired Developmental Disabilities: A Wait-List Control Group Trial Protocol | 1-gen-2024 | Barzacchi, V.; Mangani, G.; Del Lucchese, B.; Menici, V.; Bombonato, C.; Beani, E.; Biagioni, E.; Palla, I.; Posteraro, F.; Trieste, L.; Turchetti, G.; Sgandurra, G.; Cioni, G. | |
| Correction to: RarERN Path: a methodology towards the optimisation of patients’ care pathways in rare and complex diseases developed within the European Reference Networks (Orphanet Journal of Rare Diseases, (2020), 15, 1, (347), 10.1186/s13023-020-01631-1) | 1-gen-2021 | Talarico, R.; Cannizzo, S.; Lorenzoni, V.; Marinello, D.; Palla, I.; Pirri, S.; Ticciati, S.; Trieste, L.; Triulzi, I.; Terol, E.; Bucher, A.; Turchetti, G. | |
| Longitudinal adherence trajectories to biologic disease modifying anti-rheumatic drugs in Tuscany, Italy | 1-gen-2021 | Giometto, S; Convertino, I; Tuccori, M; Gini, R; Cazzato, M; Valdiserra, G; Cappello, E; Ferraro, S; Tillati, S; Fornili, M; Bartolini, C; Paoletti, O; Turchetti, G; Trieste, L; Lorenzoni, V; Blandizzi, C; Mosca, M; Lucenteforte, E | |
| Utilisation patterns and clinical impact of the introduction of infliximab-biosimilar in Tuscany, Italy: real world evidence following the recommendation of switching for non-medical reasons | 1-gen-2021 | Convertino, Irma; Lucenteforte, Ersilia; Gini, Rosa; Lorenzoni, Valentina; Cazzato, Massimiliano; Turchetti, Giuseppe; Trieste, Leopoldo; Ferraro, Sara; Leonardi, Luca; Roberto, Giuseppe; Luciano, Nicoletta; Blandizzi, Corrado; Mosca, Marta; Tuccori, Marco | |
| Validation of algorithms for selecting rheumatoid arthritis patients in the Tuscan healthcare administrative databases | 1-gen-2021 | Convertino, I.; Cazzato, M.; Giometto, S.; Gini, R.; Valdiserra, G.; Cappello, E.; Ferraro, S.; Tillati, S.; Bartolini, C.; Paoletti, O.; Lorenzoni, V.; Trieste, L.; Filippi, M.; Turchetti, G.; Cristofano, M.; Blandizzi, C.; Mosca, M.; Lucenteforte, E.; Tuccori, M. | |
| Validation test for algorithms to identify rheumatoid arthritis patients in the Tuscan healthcare administrative databases | 1-gen-2021 | Convertino, I; Cazzato, M; Giometto, S; Gini, R; Lucenteforte, E; Valdiserra, G; Cappello, E; Ferraro, S; Tillati, S; Fornili, M; Bartolini, C; Paoletti, O; Lorenzoni, V; Trieste, L; Filippi, M; Turchetti, G; Cristofano, M; Blandizzi, C; Mosca, M; Tuccori, M | |
| RarERN Path: a methodology towards the optimisation of patients’ care pathways in rare and complex diseases developed within the European Reference Networks | 1-gen-2020 | Talarico, Rosaria; Cannizzo, Sara; Lorenzoni, Valentina; Marinello, Diana; Palla, Ilaria; Pirri, Salvatore; Ticciati, Simone; Trieste, Leopoldo; Triulzi, Isotta; Terol, Enrique; Bucher, Anna; Turchetti, Giuseppe | |
| Trajectories of use of biologic disease modifying antirheumatic drugs in rheumatoid arthritis: A cohort study of Tuscan patients, Italy | 1-gen-2020 | Convertino, I; Giometto, S; Gini, R; Cazzato, M; Valdiserra, G; Cappello, E; Ferraro, S; Fornili, M; Turchetti, G; Lorenzoni, V; Trieste, L; Mosca, M; Blandizzi, C; Tuccori, M; Lucenteforte, E | |
| Recommendations by the Tuscan Health Authority to Use Infliximab-Biosimilar in the Clinical Practice: Safety Impact | 1-gen-2019 | Convertino, I; Lucenteforte, E; Lorenzoni, V; Turchetti, G; Trieste, L; Roberto, G; Cazzato, M; Mosca, M; Ferraro, S; Leonardi, L; Luciano, N; Gini, R; Blandizzi, C; Tuccori, M | |
| Switching from infliximab-originator to infliximab-biosimilar in rheumatologic patients: The clinical impact in Tuscan Region, Italy | 1-gen-2019 | Convertino, I; Tuccori, M; Lucenteforte, E; Mosca, M; Turchetti, G; Lorenzoni, V; Trieste, L; Ferraro, S; Leonardi, L; Roberto, G; Luciano, N; Blandizzi, C; Gini, R | |
| The Economic Impact of the Introduction of Infliximab-Biosimilar: Preliminary Results from a Study on Rheumatologic Patients in Tuscany, Italy | 1-gen-2019 | Lorenzoni, V; Trieste, L; Mosca, M; Convertino, I; Tuccori, M; Lucenteforte, E; Ferraro, S; Leonardi, L; Roberto, G; Luciano, N; Blandizzi, C; Gini, R; Turchetti, G |